{
  "docId": "019de516-48a5-7631-970d-a6192a59c040",
  "docSlug": "5b4cac48a3342d745accb48141e027b4",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 39,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "dense",
  "nDataPoints": 60,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-48a5-7631-970d-a6192a59c040/26",
  "deckHref": "/decks/019de516-48a5-7631-970d-a6192a59c040",
  "deckJsonHref": "/decks/019de516-48a5-7631-970d-a6192a59c040.json",
  "deckAnchorHref": "/decks/019de516-48a5-7631-970d-a6192a59c040#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.029,
        "w": 0.73,
        "x": 0.167,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "1. As of the first quarter of 2023, certain products were recategorized across the consumables, implantables and equipment product categories. This change was made as management believes this better aligns these products in their respective categories. Prior period presentations of product categories have been conformed to current product category structure to allow investors to evaluate results between periods on a consistent basis.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6a830a7-91ea-4114-b773-5659889ece05",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.649,
        "w": 0.907,
        "x": 0.046,
        "y": 0.17
      },
      "kind": "table",
      "text": "Rank Product/Franchises 2Q23 1Q23 FY22 4Q22 3Q22 2Q22 1 Ocuvite® + PreserVision® $104M $81M $387M $114M $98M $94M 2 Surgical Consumables¹ $102M $95M $359M $94M $85M $93M 3 SofLens® $59M $60M $246M $62M $62M $61M 4 Biotrue® ONEday $49M $52M $201M $50M $53M $49M 5 Biotrue® Solutions Franchise $49M $35M $153M $37M $39M $39M 6 Surgical Implantables¹ $47M $44M $188M $49M $45M $49M 7 Surgical Equipment¹ $46M $44M $171M $45M $42M $42M 8 renu® $43M $42M $176M $47M $44M $43M 9 Lumify® $43M $38M $131M $35M $30M $35M 10 Bausch + Lomb ULTRA® $42M $51M $177M $43M $46M $44M",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f07f4be-c0aa-4340-8b90-7057477dafe1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.56,
        "x": 0.049,
        "y": 0.08
      },
      "kind": "title",
      "text": "Top 10 Revenues (Includes FX Impact)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e0d5845-6921-4907-bcbe-a5a43a637fad",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 14,
      "beatId": "83fb7e88-f765-459a-865d-12d458331d10",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The company outlines its plans for future growth and provides additional information.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}